The Department of Obstetrics and Gynecology was founded in 1956, since 1986, the comprehensive strength of the department has been enhanced year by year, and it has become a specialty combining medical treatment, teaching, scientific research and preventive health care focusing on the diagnosis and treatment of obstetrics and gynecology difficult and serious diseases, and it was rated as a standard baby-friendly hospital in 1995.
The department has been constructed and developed for many years, forming a well-trained and skilled health care backbone team, enjoying a high reputation both inside and outside the city. There are 26 medical and nursing staff, including 2 chief physicians and professors; 5 deputy chief physicians and associate professors. The specialty is complete and the treatment means is perfect. It has gynecology, obstetrics, gynecology outpatient clinic and prenatal propaganda room. The department has 40 open beds, including 16 beds for mothers and babies in the same room, 7 family-type wards, and 1 high-risk ward. The obstetrics department takes perinatal health care as the center of serialized services. Obstetric diagnosis and monitoring of high-risk pregnant women, fetuses and newborns, to improve the health of mothers and babies, eugenics, enhance the quality of the population as a specialty, especially on perinatal prevention and treatment, prevention and treatment of hyperemesis gravidarum and breastfeeding, newborn touch quite a study.
Obstetrics and gynecology carries out diagnosis and treatment of common gynecological diseases and endocrine diseases. Application of microsurgical technology to carry out ureteral anastomosis and orthopedic surgery, the application of television laparoscopy on gynecological disease diagnosis, treatment, ovarian cysts, ectopic pregnancy and other surgical treatment. Electronic colposcopy cervical pre-cancer screening, as early diagnosis, early treatment, surgery, chemotherapy methods are complete, family planning for women of childbearing age birth control counseling and guidance, to carry out painless abortion, diagnosis and treatment of female infertility, uterine tubography in the province has a high reputation, fascial hysterectomy, uterine fibroids intervention to fill the blank of the city of Jixi, so that the level of obstetrics and gynecology specialization is in the city's leading position. Ultrasound-guided puncture automated fluid sclerosis treatment of pelvic cysts won the Third Prize of Heilongjiang Provincial Science and Technology Progress in 1997; total intrafascial hysterectomy won the Third Prize of Heilongjiang Provincial Application of New Technology in 1998; super-selective uterine artery embolization treatment of uterine fibroids won the First Prize of Science and Technology of Jixi Municipality in 2002; clinical research on TV laparoscopic surgery won the Second Prize of Science and Technology Progress of Jixi Municipality in 2001; intrafascial hysterectomy won the Second Prize for Progress; Second Prize for Science and Technology Progress of Jixi City in 1998 for Total Fascial Hysterectomy; Third Prize for Science and Technology Progress of Jixi City in 1997 for Quantitative Measurement of Fibrin in Late Gestation; Third Prize for Application of New Technology of Jixi People's Hospital for Amniotic Fluid Replacement and Painless Abortion; Third Prize for Science and Technology Progress of Jixi People's Hospital for Electron Colposcopic Pre-Cancer Screening of the Cervix and Modified Vaginal Hysterectomy. Cardiovascular Disease Prevention and Control Center is set up in this department, which is responsible for the task of cardiovascular disease prevention and control in Jixi area. It has 45 open beds. Cardiovascular Internal Medicine Department **** there are 28 medical and nursing staff. Among them, 1 chief physician, 4 deputy chief physicians, 2 attending physicians, 3 residents.
Cardiovascular medicine has great influence in Jixi area. Hospital to support the development of cardiovascular medicine. Has purchased esophageal cardiac pacing stimulator, large physiological recorder, non-invasive cardiac function tester, dynamic electrocardiographic recorder, cardiac late potential tester, dynamic blood pressure monitor, cardiac activity plate test system, electrocardiographic workstation, cardiac monitor workstation in the CCU ward (cardiac monitoring system produced by the U.S. Hewlett-Packard Company), large-scale angiographic system and other equipment.
In 1989, we carried out esophageal pacing cardiac electrophysiological examination and right heart catheterization; in 1990, we carried out intravenous thrombolytic therapy for acute myocardial infarction, which greatly reduced the mortality rate of myocardial infarction and improved the healing of such patients; in 1991, we carried out the non-invasive cardiac function measurement; in 1992, we carried out the selective coronary artery angiography and percutaneous mitral balloon angioplasty; and we carried out percutaneous AV node ablation and modification, In 1992, it carried out selective coronary angiography, percutaneous mitral valve balloon angioplasty, percutaneous atrioventricular node ablation and modification, and these techniques reached the advanced level at the national level. 2000, after the purchase of a large angiography system, it set up the Jixi City Cardiology Interventional Diagnostic and Treatment Center to carry out a wide range of interventional diagnostic and therapeutic techniques for heart disease and carried out percutaneous coronary artery endocavitary balloon angioplasty and coronary stenting, peripheral vascular balloon angioplasty, percutaneous vascular puncture endocardial electrical physiological examination, percutaneous vascular puncture, and percutaneous vascular puncture endocardial electrical examination. In 1992, in cooperation with Beijing Fuwai Cardiovascular Disease Hospital, we observed the effect of captopril on the prognosis of acute myocardial infarction. 2001, in cooperation with the Sino-German Institute of Molecular Cardiology of Beijing Fuwai Cardiovascular Disease Hospital, we carried out a survey on the molecular pathology of cardiomyopathy. 2002, in cooperation with the Chinese Hypertension Alliance, we carried out a survey on the molecular pathology of cardiomyopathy. 2002, in cooperation with the Chinese Hypertension Alliance, we carried out a survey on the molecular pathology of cardiovascular disease. China Hypertension League, we carried out a study on the effect of low molecular heparin and polarizing fluid on acute myocardial infarction.
The medical and nursing staff of the Department of Cardiovascular Medicine has written a large number of papers. Since 1987, there have been "right heart catheterization", "selective coronary angiography and coronary artery balloon angioplasty, coronary artery stenting", "radiofrequency ablation treatment of supraventricular tachycardia", "percutaneous mitral valve balloon angioplasty", "permanent artificial pacemaker placement", "clinical application of intracardiac electrophysiology" and other technologies have been awarded by the Municipal and Hospital Scientific and Technological Progress Award. Dozens of papers have been published and exchanged in national and provincial magazines and academic seminars. The Department of Respiratory Medicine was established in 1989, with 24 beds, including 3 deputy chief physicians. It is the only specialized treatment department for respiratory diseases in Jixi City.
The department has strong technical force, can accurately diagnose and treat a variety of common diseases, common diseases such as bronchitis, emphysema, pulmonary heart disease, pneumonia, asthma, lung cancer, rare diseases, difficult diseases such as pulmonary embolism, pleural lesions and a variety of respiratory internal medicine series of illnesses, especially the rescue of ARDS (Acute Respiratory Distress Syndrome) success rate of 67%, with the advanced level of the domestic, the respiratory system has a critical rescue with a The department has rich clinical experience in the critical rescue of the respiratory system.
The department takes the lead in carrying out CT localization lung cancer interventional therapy, pulmonary artery embolization, fiberoptic bronchoscopy, percutaneous, lung, thorax, membrane, diaphragm puncture biopsy and other scientific research projects in Jixi City, carrying out the diagnosis and treatment of pulmonary embolism and interstitial fibrosis diagnosis and treatment research. It also has a variety of advanced therapeutic equipment such as lung function checker and intensive care monitor.